Taken together, these actions of R481 suggest that the compound does not alter glucagon secretion through a pancreatic α-cell-mediated mechanism and provides evidence that in vivo, R481 may raise glucagon levels during hypoglycemia by a centrally-mediated pathway. Here, GCG is linked to Hypoglycemia.